The Latest in Pharmacy

FDA grants drug orphan designation for CLL

August 25, 2016

Drug granted breakthrough designation for BPDCN

August 24, 2016

Drug granted orphan designation for MAS

August 22, 2016

FDA rejects antidote to factor Xa inhibitors

August 19, 2016

Drug no longer in development for DLBCL, other cancers

August 16, 2016

NICE recommending long-term ticagrelor

August 14, 2016

FDA approves drug for prevention of CINV

August 11, 2016

Ixazomib approved to treat rel/ref MM in Canada

August 9, 2016

Teva launches generic imatinib tablets in US

August 8, 2016

Products granted orphan designation for use in HSCT

August 7, 2016

Docs prescribe drugs despite possible interaction

August 3, 2016

FDA approves reconstitution system for FVIII product

August 2, 2016

HDAC inhibitor granted breakthrough designation

August 2, 2016

mAb granted breakthrough designation for MM

July 27, 2016

CHMP recommends enoxaparin biosimilars

July 24, 2016